APA (7th ed.) Citation

Müller, J., Roos, I., Kalincik, T., Lorscheider, J., Galli, E., Benkert, P., . . . Yaldizli, Ö. (2024). Escalating to medium‐ versus high‐efficacy disease modifying therapy after low‐efficacy treatment in relapsing remitting multiple sclerosis. Brain & Behavior, 14(5), 1. https://doi.org/10.1002/brb3.3498

Chicago Style (17th ed.) Citation

Müller, Jannis, et al. "Escalating to Medium‐ Versus High‐efficacy Disease Modifying Therapy After Low‐efficacy Treatment in Relapsing Remitting Multiple Sclerosis." Brain & Behavior 14, no. 5 (2024): 1. https://doi.org/10.1002/brb3.3498.

MLA (9th ed.) Citation

Müller, Jannis, et al. "Escalating to Medium‐ Versus High‐efficacy Disease Modifying Therapy After Low‐efficacy Treatment in Relapsing Remitting Multiple Sclerosis." Brain & Behavior, vol. 14, no. 5, 2024, p. 1, https://doi.org/10.1002/brb3.3498.